Intracoronary Vasoactive Therapy for No-Reflow During Primary PCI: A Network Meta-Analysis of Randomized Trials.

JACC Adv · 2026 · PMC12955103 · PMID 41740240

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

In the frequentist model, there was a nonsignificant trend toward lower mortality with adenosine, nitroprusside (OR: 0.55; 95% CI: 0.18-1.62), and verapamil (OR: 0.60; 95% CI: 0.16-2.20).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.